Latest filing published 16 Jun 2026 for Mendus AB, €31k. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Ann-Charlotte Ferm discloses dealings in 3 companies, chiefly Immunicum AB, Mendus AB and Mendus AB (publ). The record holds 48 filings, for trades running from 4 November 2021 to 12 June 2026.
The open-market side counts 42 purchases for €162k alongside 2 sales for €8,790. The net balance comes to €153k on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 3 purchases and no sales on the market.
In size, the median ticket on the buying side is €2,115. Of 41 purchases, 16 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 16 June 2026, reports an open-market purchase of €31k in Mendus AB. Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 47 declarations